This most recent twist during the Lykos Therapeutics saga threatens A serious overhaul of the corporate’s tactic and course, with Musk ally and billionaire investor Antonio Gracias showing up to wish to take the organization back again towards its nonprofit drug enhancement roots and a more Doblinite philosophy.This 7 days in copyright organizati